IP Library Granted Patent US 7,935,139
Granted Patent B2
US 7,935,139 · App. 11/005,253 · Granted May 3, 2011

Eye safe dermatological phototherapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,935,139
App. No.
11/005,253
Granted
May 3, 2011
Kind
B2
Abstract

A method and apparatus are disclosed for improving bodily safety during exposure to an intense pulsed light source by diverging the light, such as with a diffuser. At a first position of the distal end of the light source the energy density of exit light from the distal end is substantially equal to the energy density of the light required for desired applications, such as effecting an aesthetic improvement without appearance of purpura or scarring, and at a second position of the distal end the radiance of the light emitted therefrom is significantly less than the radiance of the intense pulsed light. Eye safety is further enhanced by attaching at least one element of adjustable opacity to the handpiece of the light source, so that subcutaneously backscattered light may be absorbed by the at least one element.

Claims (28)

1. An apparatus for treating a skin target, the apparatus comprising:

a light source adapted to generate eye-hazardous polychromatic light with a radiance that is more than 10*k1*k2*(t^⅓) J/cm 2 /sr, where k2=1 and t is a pulse duration of the eye-safe polychromatic light in seconds, k1=1 for a wavelength ranging from 580 to 700 nm, k1=1.3 for a wavelength of approximately 570 nm, k1=1.6 for a wavelength of approximately 830 nm, k1=3 for a wavelength of approximately 940 nm, and k1=5 for a wavelength greater than 1050 nm having a source energy density sufficient to treat a skin target;

a light guide adapted to deliver the eye-hazardous polychromatic light from the light source to a distal end of the light guide; and

a diffusing unit attachable to the distal end of the light guide and configured to contact the skin target, the diffusing unit configured (i) to receive the eye-hazardous polychromatic light from the light guide and deliver to the skin target the eye-hazardous polychromatic light having an energy density substantially equal to the source energy density when the diffusing unit is in contact with the skin target and (ii) to receive the eye-hazardous polychromatic light from the light guide and deliver at a distance from the diffusing unit eye-safe polychromatic light with a radiance that is less than 10*k1*k2*(t^⅓) J/cm 2 /sr having a second energy density substantially less than the source energy density when the diffusing unit is spaced from the skin.

2. The apparatus according to claim 1 the eye-hazardous polychromatic light has a wavelength and the energy density which is suitable for effecting a desired treatment of the skin target without formation of purpura in a vicinity of the skin target.

3. The apparatus according to claim 1 wherein the light source is capable of generating the eye-hazardous polychromatic light having a wavelength of approximately 570-900 nm.

4. The apparatus of claim 1 wherein the diffusing unit comprises an angular beam expander, a micro-prism, a diffuser, or any combination thereof.

5. The apparatus of claim 1 further comprising a coupler disposed at the distal end of the light guide.

6. The apparatus of claim 1 wherein the light source is capable of generating eye-hazardous polychromatic light having the source energy density of approximately 1 to 100 J/cm 2 , a pulse duration of approximately 100 microseconds to 1000 milliseconds, and a wavelength of approximately 400 nm to approximately 1300 nm.

7. The apparatus of claim 1 further comprising a skin cooling unit adapted to cool the diffusing unit.

8. The apparatus of claim 1 wherein the diffusing unit comprises sapphire, glass, or polycarbonate.

9. The apparatus of claim 1 wherein the diffusing unit comprises a first diffusing face and a second smooth diffusing face in opposed relation to the first diffusing face.

10. The apparatus of claim 1 wherein the light source is an intense-pulsed light source.

11. The apparatus of claim 1 wherein the eye-safe polychromatic light has a radiance less than an accessible emission limit.

12. An apparatus for treating a skin target, the apparatus comprising:

a light source adapted to generate eye-hazardous polychromatic light having a radiance of more than an accessible emission limit and a source energy density sufficient to treat a skin target;

a light guide adapted to deliver the eye-hazardous polychromatic light from the light source to a distal end of the light guide; and

a diffusing unit attachable to the distal end of the light guide and configured to contact the skin target, the diffusing unit configured (i) to receive the eye-hazardous polychromatic light from the light guide and deliver to the skin target the eye-hazardous polychromatic light having an energy density substantially equal to the source energy density when the diffusing unit is in contact with the skin target and (ii) to receive the eye-hazardous polychromatic light from the light guide and deliver at a distance from the diffusing unit eye-safe polychromatic light having a radiance of less than the accessible emission limit and a second energy density substantially less than the source energy density when the diffusing unit is spaced from the skin; and a backscattering unit attached to the light guide and having an opacity, the backscattering unit positioned to absorb substantially all of the eye-hazardous and the eye-safe polychromatic light backscattered from the skin target.

13. The apparatus of claim 12 wherein the opacity of the backscattering unit is adjustable depending on the eye-hazardous polychromatic light generated by the light source.

14. The apparatus of claim 12 wherein the opacity of the backscattering unit increases upon generation of the eye-hazardous polychromatic light by the light source.

15. The apparatus of claim 12 wherein the backscatter unit comprises a liquid crystal window, a spectral density filter, an attenuation filter, a mechanical shutter, or a combination thereof.

16. The apparatus of claim 15 wherein the attenuation filter is an optical band pass filter.

17. The apparatus of claim 12 wherein the opacity of the backscatter unit is a predetermined constant value selected based on a spectrum of the eye-hazardous polychromatic light.

18. The apparatus of claim 12 further comprising control circuitry for synchronizing the opacity of the backscatter unit in response to the generation of the eye-hazardous polychromatic light.

19. An apparatus to improve bodily safety of bystanders exposed to eye-hazardous polychromatic light, the apparatus comprising:

means for generating the eye-hazardous polychromatic light having a source energy density sufficient to treat a skin target;

means for delivering the eye-hazardous polychromatic light; and

means for (i) receiving the eye-hazardous polychromatic light with a radiance that is more than 10*k1*k2*(t^⅓) J/cm 2 /sr, where k2=1 and t is a pulse duration of the eye-safe polychromatic light in seconds, k1=1 for a wavelength ranging from 580 to 700 nm k1=1.3 for a wavelength of approximately 570 nm, k1=1.6 for a wavelength of approximately 830 nm, k1=3 for a wavelength of approximately 940 nm, and k1=5 for a wavelength greater than 1050 nm from the light guide and delivering to the skin target the eye-hazardous polychromatic light having a first energy density substantially equal to the source energy density when the diffusing unit is in contact with the skin target and (ii) receiving the eye-hazardous polychromatic light from the light guide and delivering eye-safe polychromatic light with a radiance that is less than 10*k1*k2*(t^⅓) J/cm 2 /sr and having a second energy density substantially less than the source energy density when the diffusing unit is spaced from the skin target.

Assignments (5)
NOTICE OF SUCCESSION OF AGENCY AT REEL/FRAME 059593/0269 Recorded May 29, 2026
From: BARCLAYS BANK PLC, AS PRIOR COLLATERAL AGENT
To: HSBC BANK USA, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 075648/0952 →
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Apr 4, 2022
From: CANDELA CORPORATION; SYNERON MEDICAL LTD.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059593/0269 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED AT REEL: 022368 FRAME: 0678. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 16, 2017
From: INOLASE 2002 LTD.
To: CANDELA CORPORATION
Reel/Frame 044477/0168 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →